People's Livelihood Health: Tartaric acid pheninique tablets and minoxidil ointment are expected to be launched for sale in the third quarter.

Mingsheng Health announced at the performance briefing on May 13 that the company's product, aluminum magnesium carbonate suspension, will be launched for sale by the end of 2024. The recently approved products, farnesene tablet and Minoxidil solution, are currently in the packaging design and production preparation stage, and are expected to be launched for sale in the third quarter.